Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2009175877
Up to date per 09.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2009175877
Title / Product Name
Lixisenatide zusätzlich zu Metformin und Insulin-glargin bei der Behandlung von Typ 2-Diabetes
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2009175877
EP Publication Number
2329848
E-Number
580522
Language
EN
PCT Number
-
Publication Date
08.06.2011 A
24.10.2012 B1
Registration Date
24.10.2012
AT Publication Date
15.11.2012
Application Date
13.11.2009
Registration Number
-
Priorities
-
IPC
A61K 31/155 20060101AFI20120613BHEP
Maximum Duration of Protection
13.11.2029
Owner
Sanofi-Aventis Deutschland GmbH
Brüningstraße 50
65929 Frankfurt am Main
DE
Representative
Representative
Häupl & Ellmeyer KG Patentanwaltskanzlei
Mariahilfer Straße 50 (Kirchengasse 1)
1070 Wien
AT
Inventor
Silvestre, Louise
c/o Sanofi-Aventis Département Brevets 174, Avenue de France
75013 Paris
FR
Souhami, Elisabeth
c/o Sanofi-Aventis Département Brevets 174, Avenue de France
75013 Paris
FR
Wei, Xiaodan
c/o Sanofi-Aventis 1041 Route 202-206 Mail Code: BWD-303A
Bridgewater, NJ 08807
US
Information about Fees
Click here to load the fees
see.ip - Details for Lixisenatide zusätzlich zu Metformin und Insulin-glargin bei der Behandlung von Typ 2-Diabetes